PomDoctor Debuts On Nasdaq Ahead Of New Listing Rules
1. PomDoctor raised $20 million, below new Nasdaq minimum of $25 million. 2. IPO priced at lower end, valuing PomDoctor at $472 million. 3. Company's high P/S ratio of 10 appears aggressive for current growth. 4. PomDoctor faces potential listing and financial challenges ahead. 5. Rising shares show initial investor interest, yet financial risks loom.